Insulet (NASDAQ:PODD) has received FDA clearance for an iPhone app for its Omnipod 5 insulin delivery system. The company said the approval makes Insulet the first company to offer a tubeless ...
Insulet recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery capabilities. Over the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback